Delviks-Frankenberry Krista A, Nikolenko Galina N, Barr Rebekah, Pathak Vinay K
HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA.
J Virol. 2007 Jul;81(13):6837-45. doi: 10.1128/JVI.02820-06. Epub 2007 Apr 11.
We recently observed that mutations in the human immunodeficiency type 1 (HIV-1) reverse transcriptase (RT) connection domain significantly increase 3'-azido-3'-deoxythymidine (AZT) resistance up to 536 times over wild-type (WT) RT in the presence of thymidine analog resistance mutations (TAMs). These mutations also decreased RT template switching, suggesting that they altered the balance between nucleotide excision and template RNA degradation, which in turn increased AZT resistance. Several residues in the HIV-1 connection domain contact the primer strand and form an RNase H primer grip structure that helps to position the primer-template at the RNase H and polymerase active sites. To test the hypothesis that connection domain mutations enhanced AZT resistance by influencing the RNase H primer grip, we determined the effects of alanine substitutions in RNase H primer grip residues on nucleoside RT inhibitor resistance in the context of a WT, TAM-containing, or K65R-containing polymerase domain. Ten of the 11 RNase H primer grip mutations increased AZT resistance 20 to 243 times above WT levels in the context of a TAM-containing polymerase domain. Furthermore, all mutations in the RNase H primer grip decreased template switching, suggesting that they reduced RNase H activity. These results demonstrate that mutations in the RNase H primer grip region can significantly enhance AZT resistance and support the hypothesis that mutations in the connection and RNase H domains can increase resistance by altering the RNase H primer grip region, changing interactions between RT and the template-primer complex and/or shifting the balance between the polymerase and RNase H activities.
我们最近观察到,在存在胸苷类似物抗性突变(TAM)的情况下,人类免疫缺陷病毒1型(HIV-1)逆转录酶(RT)连接域中的突变可使3'-叠氮-3'-脱氧胸苷(AZT)抗性比野生型(WT)RT显著增加高达536倍。这些突变还减少了RT模板转换,表明它们改变了核苷酸切除与模板RNA降解之间的平衡,进而增加了AZT抗性。HIV-1连接域中的几个残基与引物链接触并形成一个核糖核酸酶H引物握持结构,有助于将引物-模板定位在核糖核酸酶H和聚合酶活性位点。为了验证连接域突变通过影响核糖核酸酶H引物握持来增强AZT抗性这一假说,我们在野生型、含TAM或含K65R的聚合酶结构域背景下,测定了核糖核酸酶H引物握持残基的丙氨酸取代对核苷RT抑制剂抗性的影响。在含TAM的聚合酶结构域背景下,11个核糖核酸酶H引物握持突变中有十个使AZT抗性比野生型水平增加了20至243倍。此外,核糖核酸酶H引物握持中的所有突变都减少了模板转换,表明它们降低了核糖核酸酶H活性。这些结果表明,核糖核酸酶H引物握持区域中的突变可显著增强AZT抗性,并支持以下假说:连接域和核糖核酸酶H结构域中的突变可通过改变核糖核酸酶H引物握持区域、改变RT与模板-引物复合物之间的相互作用和/或改变聚合酶与核糖核酸酶H活性之间的平衡来增加抗性。